Gabriel Lazaro-Munoz
Overview
Explore the profile of Gabriel Lazaro-Munoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iyer S, Maxson Jones K, Robinson J, Provenza N, Duncan D, Lazaro-Munoz G, et al.
Elife
. 2024 Nov;
13.
PMID: 39602224
In this paper, we provide an overview and analysis of the BRAIN Initiative data-sharing ecosystem. First, we compare and contrast the characteristics of the seven BRAIN Initiative data archives germane...
2.
Cenolli I, Campbell T, Dorfman N, Hurley M, Smith J, Kostick-Quenet K, et al.
AJOB Empir Bioeth
. 2024 Sep;
16(1):32-41.
PMID: 39250769
Introduction: Deep brain stimulation (DBS) is approved under a humanitarian device exemption to manage treatment-resistant obsessive-compulsive disorder (TR-OCD) in adults. It is possible that DBS may be trialed or used...
3.
van Stuijvenberg O, Versalovic E, Lazaro-Munoz G, Zuk P
AJOB Neurosci
. 2024 Jul;
15(3):181-184.
PMID: 39018228
No abstract available.
4.
White A, Kelly-Hedrick M, Miranda S, Abdelbarr M, Lazaro-Munoz G, Pouratian N, et al.
World Neurosurg
. 2024 Jul;
190:181-186.
PMID: 39004179
Neurosurgery is a field with complex ethical issues. In this article, we aim to provide an overview of key and emerging ethical issues in neurosurgery with a focus on issues...
5.
Merner A, Trotter P, Ginn L, Bach J, Freedberg K, Soda T, et al.
Psychiatry Res
. 2024 Jul;
339:116080.
PMID: 39002500
Recent advances in psychiatric genetics have enabled the use of polygenic risk scores (PRS) to estimate genetic risk for psychiatric disorders. However, the potential use of PRS in child and...
6.
Furrer R, Merner A, Stevens I, Zuk P, Williamson T, Shen F, et al.
medRxiv
. 2024 Jul;
PMID: 38946963
Background: Advances in the development of neurotechnologies have the potential to revolutionize treatment of brain-based conditions. However, a critical concern revolves around the willingness of the public to embrace these...
7.
Furrer R, Barlevy D, Pereira S, Carmi S, Lencz T, Lazaro-Munoz G
JAMA Netw Open
. 2024 May;
7(5):e2410832.
PMID: 38743425
Importance: Polygenic embryo screening (PES) is a novel technology that estimates the likelihood of developing future conditions (eg, diabetes or depression) and traits (eg, height or cognitive ability) in human...
8.
Definition of Implanted Neurological Device Abandonment: A Systematic Review and Consensus Statement
Okun M, Marjenin T, Ekanayake J, Gilbert F, Doherty S, Pilkington J, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e248654.
PMID: 38687486
Importance: Establishing a formal definition for neurological device abandonment has the potential to reduce or to prevent the occurrence of this abandonment. Objective: To perform a systematic review of the...
9.
Smith J, Dorfman N, Hurley M, Cenolli I, Kostick-Quenet K, Storch E, et al.
Camb Q Healthc Ethics
. 2024 Apr;
:1-14.
PMID: 38602092
The ongoing debate within neuroethics concerning the degree to which neuromodulation such as deep brain stimulation (DBS) changes the personality, identity, and agency (PIA) of patients has paid relatively little...
10.
Johnson K, Dosenbach N, Gordon E, Welle C, Wilkins K, Bronte-Stewart H, et al.
Front Hum Neurosci
. 2024 Mar;
18:1320806.
PMID: 38450221
The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9-11, 2023 in Gainesville, Florida with the theme of "Pushing the Forefront of Neuromodulation". The keynote speaker was...